218 related articles for article (PubMed ID: 14986591)
1. High-dose tamoxifen modulates drug resistance to doxorubicin, dacarbazine and ifosfamide in metastatic uterine leiomyosarcoma.
Yeh KH; Lu YS; Hsiao CH; Cheng AL
Anticancer Res; 2003; 23(6D):5133-7. PubMed ID: 14986591
[TBL] [Abstract][Full Text] [Related]
2. Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: a report of two cases.
Minobe S; Todo Y; Suzuki Y; Aoyagi Y; Umazume T; Okamoto K; Kato H
J Obstet Gynaecol Res; 2011 Jun; 37(6):645-9. PubMed ID: 21375676
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: a Gynecologic Oncology Group study.
Long HJ; Blessing JA; Sorosky J
Gynecol Oncol; 2005 Nov; 99(2):339-42. PubMed ID: 16051328
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.
Sutton G; Blessing JA; Malfetano JH
Gynecol Oncol; 1996 Aug; 62(2):226-9. PubMed ID: 8751554
[TBL] [Abstract][Full Text] [Related]
5. [Metastatic lung tumor from uterine leiomyosarcoma].
Nishida T; Shoji S; Itoh T; Minami H; Akizuki K; Ozuno I; Kageyama H; Ozaki I; Yamamoto K; Yamamoto A; Nishiyama N
Kyobu Geka; 2006 Dec; 59(13):1191-6. PubMed ID: 17163213
[TBL] [Abstract][Full Text] [Related]
6. High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung.
Yeh KH; Cheng AL
Anticancer Res; 1997; 17(2B):1341-3. PubMed ID: 9137495
[TBL] [Abstract][Full Text] [Related]
7. Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
Hadoux J; Rey A; Duvillard P; Lhommé C; Balleyguier C; Haie-Meder C; Morice P; Tazi Y; Leary A; Larue C; Pautier P
Int J Gynecol Cancer; 2015 Feb; 25(2):296-302. PubMed ID: 25581897
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy CYVADIC and adriamycin (injected intratumorally) result in a partial response for six months in uterine sarcoma recurrence].
Higashijima H; Yoh S; Kataoka A; Arimatsu T; Tanaka H; Araki T; Nishida K; Umezu J
Igaku Kenkyu; 1986 Jun; 56(2):77-84. PubMed ID: 3564864
[No Abstract] [Full Text] [Related]
9. Hysteroscopic resection of uterine leiomyosarcoma: a case report and literature review.
Nappi L; Di Spiezio Sardo A; Indraccolo U; Bettocchi S
J Minim Invasive Gynecol; 2008; 15(3):380-3. PubMed ID: 18439518
[TBL] [Abstract][Full Text] [Related]
10. Ifosfamide with and without adriamycin in advanced uterine leiomyosarcoma.
Hawkins RE; Wiltshaw E; Mansi JL
Cancer Chemother Pharmacol; 1990; 26 Suppl():S26-9. PubMed ID: 2347045
[TBL] [Abstract][Full Text] [Related]
11. Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for gynecological sarcomas.
Pearl ML; Inagami M; McCauley DL; Valea FA; Chalas E; Fischer M
Int J Gynecol Cancer; 2002; 12(6):745-8. PubMed ID: 12445253
[TBL] [Abstract][Full Text] [Related]
12. Treatment of metastatic uterine leiomyosarcoma with cisplatin, pirarubicin, and ifosfamide.
Hirota Y; Miyamura K; Hayata T; Miyakawa I
Gynecol Obstet Invest; 1997; 44(1):70-2. PubMed ID: 9251960
[TBL] [Abstract][Full Text] [Related]
13. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
[TBL] [Abstract][Full Text] [Related]
14. Myxoid leiomyosarcoma of the uterus.
Kunzel KE; Mills NZ; Muderspach LI; d'Ablaing G
Gynecol Oncol; 1993 Feb; 48(2):277-80. PubMed ID: 8428703
[TBL] [Abstract][Full Text] [Related]
15. [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
Li EX; Zhang YT; Shang JT; Xu Z; Geng Y; Li SM; Shi F; Wu YY
Ai Zheng; 2006 Aug; 25(8):1048-51. PubMed ID: 16965692
[TBL] [Abstract][Full Text] [Related]
16. Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas.
Edmonson JH; Marks RS; Buckner JC; Mahoney MR
Cancer Invest; 2002; 20(5-6):605-12. PubMed ID: 12197215
[TBL] [Abstract][Full Text] [Related]
17. [Neoadjuvant CYVADIC (cyclophosphamide, vincristine, adriamycin and dacarbazine) therapy for retroperitoneal leiomyosarcoma: a case report].
Kamba T; Kawakita M; Noguchi T; Kamoto T; Okabe T; Takeuchi E; Matsumoto M
Hinyokika Kiyo; 1997 Aug; 43(8):577-80. PubMed ID: 9310781
[TBL] [Abstract][Full Text] [Related]
18. Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor.
Hardman MP; Roman JJ; Burnett AF; Santin AD
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):518-20. PubMed ID: 17666649
[TBL] [Abstract][Full Text] [Related]
19. [Remission due to CYVADIC chemotherapy of primary leiomyosarcoma derived from mesentelium of the sigmoid colon: a case report].
Takano M; Kita T; Kikuchi Y; Nagata I
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1487-90. PubMed ID: 10500540
[TBL] [Abstract][Full Text] [Related]
20. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]